ArticleOncology letters2025
Dynamic whole-body positron emission tomography/computed tomography for predicting treatment response to chemoradiotherapy in patients with esophageal cancer.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bone marrow SUVmax onImmunologic research · 2026Article
- CT-to-PET Synthesis in the Head-Neck and Thoracic Region via Conditional 3D Latent Diffusion Modeling.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most positron emission tomography/computed tomography (PET/CT) studies are based on static whole-body images; however, dynamic whole-body PET/CT (DW-PET/CT) enables quantification of tissue glucose metabolism dynamics. The aim of the present study was to investigate whether DW-PET/CT can predict treatment response in patients with esophageal squamous cell carcinoma (ESCC) treated with chemoradiotherapy (CRT). A total of 56 patients with ESCC who underwent pretreatment DW-PET/CT were evaluated. DW-PET/CT parameters of the main tumor, including the Patlak slope (PS, absolute rate of tracer consumption) and Patlak intercept (PI, degree of tracer perfusion in the tumor), were calculated using four DW-PET/CT image series acquired every 5 min starting 60 min after injection of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.